C9orf72 and amyotrophic lateral sclerosis: The ongoing problem of diagnostic antibody variability is highlighted well by a recent paper which tested 16 commercial antibodies (from seven different vendors) to C9ORF72, a protein specific to amyotrophic lateral sclerosis (ALS) [11].